https://www.gosh.nhs.uk/news/chief-executive-mat-shaw-to-take-up-additional-role/
Chief Executive Mat Shaw to take up additional role
4 Dec 2023, 5 p.m.
The Chief Executive of Great Ormond Street Hospital (GOSH), Mat Shaw, has become Whittington Health NHS Trust’s Interim Accountable Officer. This role is in addition to his role at GOSH.
The Trust’s current CEO, Helen Brown, will be undertaking an assignment with NHS London on provider collaboratives. This is a decision she has taken for personal reasons.
Mat will be in this temporary role until the end of February 2024. Due to his expanded leadership remit, a temporary role of Deputy Chief Executive has been introduced at GOSH. This is to help ensure that the hospital continues to work to deliver the highest quality, safe care and an excellent patient experience to our young patients and their families. Dr Sanjiv Sharma, GOSH’s Chief Medical Officer, has been appointed to the additional role of Acting Deputy Chief Executive.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)
By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer